Hikma Pharmaceuticals Appoints Kristy Ronco Executive Vice President, Sales and Marketing, Generics

Hikma Pharmaceuticals USA Inc., a wholly owned subsidiary of Hikma Pharmaceuticals PLC (“Hikma”) (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY), today announced the appointment of Kristy Ronco as Executive Vice President, Sales and Marketing for its Generics Division. Ms. Ronco will be responsible for leading Generics’ retail sales, addiction therapy sales and branded sales teams.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180816005263/en/

Hikma Pharmaceuticals Appoints Kristy Ronco Executive Vice President, Sales and Marketing, Generics (Photo: Business Wire)

She will also oversee marketing, pricing, forecasting and analytics.

“Kristy is a talented leader with significant pharmaceutical industry experience across sales, marketing, operations, market analysis, contracts and pricing, and we are delighted she is joining our team,” said Brian Hoffmann, President of Hikma’s Generics Division. “I am looking forward to working closely with Kristy and her team to deliver substantial value to our customers, employees and the broader communities we serve.”

Ms. Ronco joins Hikma after 11 years at Zydus Pharmaceuticals where she was most recently Senior Vice President, Sales and Marketing. Earlier in her career, she held successive positions of increasing responsibility in marketing, contracts, pricing and market analysis at TEVA, Sandoz, Aventis and Johnson & Johnson. Ms. Ronco is also a registered nurse with extensive clinical patient-care experience across a range of medical disciplines and specialties.

”I am thrilled to be joining Hikma’s Generics business and look forward to helping the company fulfill its vital mission of producing and distributing high-quality generic medicines that each day put better health within reach of millions of people,” said Ms. Ronco.

-- ENDS --

About Hikma

Hikma helps put better health within reach every day for millions of people in more than 50 countries around the world. For 40 years, we’ve been creating high-quality medicines and making them accessible to the people who need them. We're a global company with a local presence across the United States (US), the Middle East and North Africa (MENA) and Europe, and we use our unique insight and expertise to transform cutting-edge science into innovative solutions that transform people's lives. We're committed to our customers, and the people they care for, and by thinking creatively and acting practically, we provide them with a broad range of branded and non-branded generic medicines. Together, our 8,500 colleagues are helping to shape a healthier world that enriches all our communities. We are a leading licensing partner in the MENA region, and through our venture capital arm, are helping bring innovative health technologies to people around the world. For more information, please visit www.hikma.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20180816005263/en/

Hikma Pharmaceuticals USA Inc.Steven [e-mail]732.720.2830 (office)732.788.8279 (mobile)